To determine whether disease activity, treatment, IGHV mutational status, Binet stage, blood number counts, and percentage of CLL cells affect the expression level of investigated markers on neutrophils, we compared the expression of CD54, CD11b, CD62L, and CD64 in CLL subgroups. The gene discussed is ITGAM; the disease is B-cell chronic lymphocytic leukemia.